ABVC BIOPHARMA, INC.

Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.

ABVC | NDAQ

Overview

Corporate Details

ISIN(s):: US00091F1066
LEI:
Country:: United States of America
Address:: 44370 OLD WARM SPRINGS BLVD., 94538 FREMONT
Website:: https://abvcpharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing drugs and medical devices for unmet medical needs. The company specializes in botanical, plant-based therapies designed for high efficacy and low toxicity. Its development pipeline targets conditions in ophthalmology, oncology, and Central Nervous System (CNS) disorders, including major depressive disorder and adult ADHD. Key products in development include Vitargus®, a biodegradable vitreous replacement, and novel treatments for depression (ABV-1504) and ADHD (ABV-1505). The company in-licenses promising compounds from a global network of research institutions to advance them through clinical trials. Additionally, its subsidiary, BioKey, Inc., provides contract development and manufacturing services for nutritional and pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ABVC BIOPHARMA, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABVC BIOPHARMA, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ABVC BIOPHARMA, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
FTAI Infrastructure Inc. Develops, acquires, and operates critical infrastructure in rail, ports, power, and gas.	United States of America	FIP
FunPep Company Limited Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.	Japan	4881
Gain Therapeutics, Inc. Using an AI platform to develop allosteric therapies for neurodegenerative diseases.	United States of America	GANX
GALAPAGOS NV Developing a rapid, decentralized cell therapy platform for oncology and immunology.	United States of America	GLPG
Galaxy Payroll Group Ltd APAC cross-border payroll, EOR, and corporate services for global businesses.	United States of America	GLXG
GATX CORP Global lessor of railcars, locomotives, and spare aircraft engines for key industries.	United States of America	GATX
GECOSS CORPORATION Leases and sells temporary steel materials and equipment for large construction projects.	Japan	9991
GENDAI AGENCY INC. Advertising agency providing marketing and promotions for the pachinko industry.	Japan	2411
Geneuro Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.	Switzerland	GEM
Genexine, Inc. Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.	South Korea	095700